FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981070626> ?p ?o ?g. }

• W2981070626 abstract "In the era of targeted therapy and immunotherapy, the objective of dose finding is often to identify the optimal biological dose (OBD), rather than the maximum tolerated dose. We develop a utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to find the OBD. We jointly model toxicity and efficacy using a multinomial‐Dirichlet model, and employ a utility function to measure dose risk‐benefit trade‐off. The U‐BOIN design consists of two seamless stages. In stage I, the Bayesian optimal interval design is used to quickly explore the dose space and collect preliminary toxicity and efficacy data. In stage II, we continuously update the posterior estimate of the utility for each dose after each cohort, using accumulating efficacy and toxicity from both stages I and II, and then use the posterior estimate to direct the dose assignment and selection. Compared to existing phase I/II designs, one prominent advantage of the U‐BOIN design is its simplicity for implementation. Once the trial is designed, it can be easily applied using predetermined decision tables, without complex model fitting and estimation. Our simulation study shows that, despite its simplicity, the U‐BOIN design is robust and has high accuracy to identify the OBD. We extend the design to accommodate delayed efficacy by leveraging the short‐term endpoint (eg, immune activity or other biological activity of targeted agents), and using it to predict the delayed efficacy outcome to facilitate real‐time decision making. A user‐friendly software to implement the U‐BOIN is freely available at www.trialdesign.org ." @default.
• W2981070626 created "2019-10-25" @default.
• W2981070626 creator A5019360674 @default.
• W2981070626 creator A5025719568 @default.
• W2981070626 creator A5041570474 @default.
• W2981070626 date "2019-10-17" @default.
• W2981070626 modified "2023-10-16" @default.
• W2981070626 title "A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies" @default.
• W2981070626 cites W157796586 @default.
• W2981070626 cites W1963537211 @default.
• W2981070626 cites W1988289042 @default.
• W2981070626 cites W2024963690 @default.
• W2981070626 cites W2027769492 @default.
• W2981070626 cites W2039941561 @default.
• W2981070626 cites W2046420108 @default.
• W2981070626 cites W2050950840 @default.
• W2981070626 cites W2070785973 @default.
• W2981070626 cites W2076108528 @default.
• W2981070626 cites W2108441636 @default.
• W2981070626 cites W2129546350 @default.
• W2981070626 cites W2138223122 @default.
• W2981070626 cites W2167228337 @default.
• W2981070626 cites W2277432382 @default.
• W2981070626 cites W2315885933 @default.
• W2981070626 cites W2361507841 @default.
• W2981070626 cites W2512255557 @default.
• W2981070626 cites W2513194852 @default.
• W2981070626 cites W2619747939 @default.
• W2981070626 cites W2758838926 @default.
• W2981070626 cites W2793259039 @default.
• W2981070626 cites W2799795409 @default.
• W2981070626 cites W2883290014 @default.
• W2981070626 cites W3100078220 @default.
• W2981070626 cites W3106333376 @default.
• W2981070626 cites W41222772 @default.
• W2981070626 doi "https://doi.org/10.1002/sim.8361" @default.
• W2981070626 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7927960" @default.
• W2981070626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31621952" @default.
• W2981070626 hasPublicationYear "2019" @default.
• W2981070626 type Work @default.
• W2981070626 sameAs 2981070626 @default.
• W2981070626 citedByCount "46" @default.
• W2981070626 countsByYear W29810706262020 @default.
• W2981070626 countsByYear W29810706262021 @default.
• W2981070626 countsByYear W29810706262022 @default.
• W2981070626 countsByYear W29810706262023 @default.
• W2981070626 crossrefType "journal-article" @default.
• W2981070626 hasAuthorship W2981070626A5019360674 @default.
• W2981070626 hasAuthorship W2981070626A5025719568 @default.
• W2981070626 hasAuthorship W2981070626A5041570474 @default.
• W2981070626 hasBestOaLocation W29810706262 @default.
• W2981070626 hasConcept C105795698 @default.
• W2981070626 hasConcept C107673813 @default.
• W2981070626 hasConcept C114614502 @default.
• W2981070626 hasConcept C119857082 @default.
• W2981070626 hasConcept C154945302 @default.
• W2981070626 hasConcept C186394612 @default.
• W2981070626 hasConcept C2776214188 @default.
• W2981070626 hasConcept C2777334693 @default.
• W2981070626 hasConcept C2778067643 @default.
• W2981070626 hasConcept C2779377595 @default.
• W2981070626 hasConcept C33923547 @default.
• W2981070626 hasConcept C41008148 @default.
• W2981070626 hasConcept C44249647 @default.
• W2981070626 hasConcept C535046627 @default.
• W2981070626 hasConcept C60644358 @default.
• W2981070626 hasConcept C86803240 @default.
• W2981070626 hasConceptScore W2981070626C105795698 @default.
• W2981070626 hasConceptScore W2981070626C107673813 @default.
• W2981070626 hasConceptScore W2981070626C114614502 @default.
• W2981070626 hasConceptScore W2981070626C119857082 @default.
• W2981070626 hasConceptScore W2981070626C154945302 @default.
• W2981070626 hasConceptScore W2981070626C186394612 @default.
• W2981070626 hasConceptScore W2981070626C2776214188 @default.
• W2981070626 hasConceptScore W2981070626C2777334693 @default.
• W2981070626 hasConceptScore W2981070626C2778067643 @default.
• W2981070626 hasConceptScore W2981070626C2779377595 @default.
• W2981070626 hasConceptScore W2981070626C33923547 @default.
• W2981070626 hasConceptScore W2981070626C41008148 @default.
• W2981070626 hasConceptScore W2981070626C44249647 @default.
• W2981070626 hasConceptScore W2981070626C535046627 @default.
• W2981070626 hasConceptScore W2981070626C60644358 @default.
• W2981070626 hasConceptScore W2981070626C86803240 @default.
• W2981070626 hasFunder F4320332161 @default.
• W2981070626 hasIssue "28" @default.
• W2981070626 hasLocation W29810706261 @default.
• W2981070626 hasLocation W29810706262 @default.
• W2981070626 hasOpenAccess W2981070626 @default.
• W2981070626 hasPrimaryLocation W29810706261 @default.
• W2981070626 hasRelatedWork W1880559433 @default.
• W2981070626 hasRelatedWork W1972194651 @default.
• W2981070626 hasRelatedWork W1985846739 @default.
• W2981070626 hasRelatedWork W2063214645 @default.
• W2981070626 hasRelatedWork W2137226750 @default.
• W2981070626 hasRelatedWork W2146620998 @default.
• W2981070626 hasRelatedWork W2226294016 @default.
• W2981070626 hasRelatedWork W239577987 @default.
• W2981070626 hasRelatedWork W2781164451 @default.
• W2981070626 hasRelatedWork W4221142065 @default.
• W2981070626 hasVolume "38" @default.

• next